MetaADEDB 2.0 @ LMMD
ferrous sulfate
(BAUYGSIQEAFULO-UHFFFAOYSA-L)
Structure
SMILES
[O-]S(=O)(=O)[O-].[Fe+2]
Type(s)
Approved
Molecular Formula:
FeO4S
Molecular Weight:
151.908
Log P:
-0.2597
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
88.64
CAS Number(s):
7720-78-7; 8063-79-4; 16547-58-3
Synonym(s)
1.
ferrous sulfate
2.
Aktiferrin
3.
Apo-Ferrous Sulfate
4.
Ceferro
5.
Conferon
6.
Eisendragees-ratiopharm
7.
Eisensulfat Stada
8.
FERROinfant
9.
Feospan
10.
Fer-Gen-Sol
11.
Fer-in-Sol
12.
Feratab
13.
Fero-Gradumet
14.
Ferodan
15.
Ferogradumet
16.
Ferro-Gradumet
17.
Ferrogamma
18.
Ferrograd
19.
Haemoprotect
20.
Hemobion
21.
Hemofer
22.
Hämatopan
23.
Kendural
24.
Mol-Iron
25.
Plastufer
26.
Slow-Fe
27.
Vitaferro Kapseln
28.
biofer
29.
ferrous sulfate, heptahydrate
30.
ferrous sulphate
31.
iron(II) sulfate heptahydrate
External Link(s)
MeSHC020748
PubChem Compound24393
62662
ChEBI75832
CHEMBLCHEMBL1200830
DrugBankDB13257
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ConstipationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
2VomitingFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
3GastritisFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
4Abdominal PainFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
5Toxicity to various agentsFAERS: 6US FAERS
6Accidental exposure to productFAERS: 5US FAERS
7Chest discomfortFAERS: 3US FAERS
8Metabolic acidosisFAERS: 3US FAERS
9OverdoseFAERS: 3US FAERS
10ShockFAERS: 3US FAERS
11SomnolenceFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Blood pressure immeasurableFAERS: 2US FAERS
13Completed SuicideFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
14DizzinessFAERS: 2US FAERS
15Drug dispensing errorFAERS: 2US FAERS
16Foreign body aspirationFAERS: 2US FAERS
17HeadacheFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Impaired gastric emptyingFAERS: 2US FAERS
19Medication ErrorFAERS: 2US FAERS
20NauseaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Post procedural bile leakFAERS: 2US FAERS
22PresyncopeFAERS: 2US FAERS
23Product quality issueFAERS: 2US FAERS
24Accidental exposure to product by childFAERS: 1US FAERS
25Acute left ventricular failureFAERS: 1US FAERS
26AngioedemaFAERS: 1US FAERS
27AtelectasisFAERS: 1US FAERS
28Atrial FibrillationFAERS: 1US FAERS
29Back PainFAERS: 1US FAERS
30Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
31Breast tendernessFAERS: 1US FAERS
32Burkholderia cepacia complex infectionFAERS: 1US FAERS
33Cardiac ArrestFAERS: 1US FAERS
34Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
35Drug administration errorFAERS: 1US FAERS
36Drug ineffectiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Drug toxicityFAERS: 1US FAERS
38Duodenal UlcerFAERS: 12899203CTD
US FAERS
39DysuriaFAERS: 1US FAERS
40ErythemaFAERS: 1US FAERS
41Gastric ulcerFAERS: 1US FAERS
42Hepatic necrosisFAERS: 1US FAERS
43Hepatorenal SyndromeFAERS: 1US FAERS
44HypotensionFAERS: 1US FAERS
45Incorrect dose administeredFAERS: 1US FAERS
46Incorrect route of drug administrationFAERS: 1US FAERS
47InfectionFAERS: 1US FAERS
48Intentional product use issueFAERS: 1US FAERS
49Lung consolidationFAERS: 1US FAERS
50MalaiseFAERS: 1US FAERS
51Maternal exposure during pregnancyFAERS: 1US FAERS
52Mental status changesFAERS: 1US FAERS
53Night sweatsFAERS: 1US FAERS
54Ocular discomfortFAERS: 1US FAERS
55OliguriaFAERS: 1US FAERS
56PalpitationsFAERS: 1US FAERS
57PneumoniaFAERS: 1US FAERS
58Product contaminationFAERS: 1US FAERS
59Product dosage form confusionFAERS: 1US FAERS
60Product label confusionFAERS: 1US FAERS
61Product substitution issueFAERS: 1US FAERS
62Product use issueFAERS: 1US FAERS
63Rash erythematousFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Respiratory tract inflammationFAERS: 1US FAERS
65RetchingFAERS: 1US FAERS
66ScabFAERS: 1US FAERS
67Stoma obstructionFAERS: 1US FAERS
68StomatitisFAERS: 1US FAERS
69StridorFAERS: 1US FAERS
70Transcription medication errorFAERS: 1US FAERS
71UrticariaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
72Wrong doseFAERS: 1US FAERS
73Abdominal discomfortCanada Vigilance: 3Canada Vigilance
74Accidental overdoseCanada Vigilance: 2Canada Vigilance
75Anemia20051288CTD
76AngerCanada Vigilance: 1Canada Vigilance
77Blood Coagulation Disorders6421970CTD
78Blood iron decreasedCanada Vigilance: 1Canada Vigilance
79Blood iron increasedCanada Vigilance: 1Canada Vigilance
80CyanosisCanada Vigilance: 2Canada Vigilance
81DysphoniaCanada Vigilance: 1Canada Vigilance
82Feeling abnormalCanada Vigilance: 1Canada Vigilance
83Head discomfortCanada Vigilance: 1Canada Vigilance
84HepatitisCanada Vigilance: 1Canada Vigilance
85Inflammation23692848CTD
86Nerve Degeneration28583816CTD
87PruritusCanada Vigilance: 2Canada Vigilance
88SyncopeCanada Vigilance: 1Canada Vigilance
89TinnitusCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.